News for Healthier Living

Moffitt Researchers Develop Mathematical Measures to Better Personalize Therapy for Prostate Cancer

Researchers at Moffitt Cancer Center have developed three mathematical biomarkers that may help physicians personalize adaptive therapy for prostate cancer by predicting treatment outcomes early in treatment. The biomarkers are specialized mathematical measures calculated from routine prostate-specific antigen (PSA) blood tests.

August 12, 2026


August 13 2026

August 12 2026

August 11 2026

August 10 2026

August 7 2026

August 6 2026

August 5 2026

August 4 2026

August 3 2026

August 1 2026

July 31 2026

July 30 2026